Who Cares About the Past?

Similar documents
Conceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014.

New Paradigms in Predicting CVD Risk

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Diagnostic and Prognostic Value of Coronary Ca Score

Title for Paragraph Format Slide

1. Which one of the following patients does not need to be screened for hyperlipidemia:

CARDIAC IMAGING FOR SUBCLINICAL CAD

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

Best Lipid Treatments

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.

PCSK9 Inhibitors and Modulators

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Investigating senior athletes for cardiovascular disease. Antonio Pelliccia, MD

Coronary Artery Thermography

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study

FFR-CT Not Ready for Primetime

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging

Potential recommendations for CT coronary angiography in athletes

Current and Future Imaging Trends in Risk Stratification for CAD

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Coronary Artery Calcification

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

Cardiac CT Angiography

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm

Imaging Atheroma The quest for the Vulnerable Plaque

Is computed tomography angiography really useful in. of coronary artery disease?

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment

Welcome! To submit questions during the presentation: or Text:

Intervention: How and to which extent is technology helping us?

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

Defining Severe Familial Hypercholesterolemia. Raul D. Santos MD, PhD Brazil

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

Familial hypercholesterolaemia in children and adolescents

Risk Stratification for CAD for the Primary Care Provider

The Diabetes Link to Heart Disease

Dr Chris Ellis. Consultant Cardiologist Auckland City Hospital Auckland. 11:30-12:00 ECGs for Nurses, and The Basics of CT Heart Scanning

Women and Heart Disease

Diabetes and Occult Coronary Artery Disease

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong

40% minimum reduction from

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

Are We Ready for a Paradigm Shift From Risk Factors to Detection of Subclinical Coronary Atherosclerosis? Lessons From MESA. Khurram Nasir, MD MPH

Women and Coronary Artery Disease:

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Kumar S, Sharma S. Department of Cardiac Radiology, AIIMS, New Delhi, India

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?

Learning Objectives. Patient Case

Pathophysiology of Coronary Microvascular Dysfunction

Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah. March 2017

Testing the Asymptomatic CAD Patient: When and Why?

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Women and Vascular Disease

CLINICAL OUTCOME Vs SURROGATE MARKER

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Maria Angela S. Cruz-Anacleto, MD

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement

Malaysian Healthy Ageing Society

2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP

VALVULO-METABOLIC RISK IN AORTIC STENOSIS

Characteristics of Subclinical Coronary Artery Disease in Diabetic Patients without Known Coronary Artery Disease

Joshua A. Beckman, MD. Brigham and Women s Hospital

Corporate Medical Policy

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Disclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Short and Long Term Prognosis after Coronary Artery Calcium Scoring

Dr. Suzanne Steinbaum Director, Women and Heart Disease Lenox Hill Hospital New York

PET myocard perfusion & viability Riemer Slart

actually rupture! Challenges to the vulnerable plaque concept

Coronary Artery Calcium to Predict All-Cause Mortality in Elderly Men and Women

Statins for Cardiovascular Disease Prevention in Women: Review of the Evidence

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6

Reducing Cardiovascular Risk in Adults. ACC Guidelines for Cholesterol Reduction: NCEP ATP CAOM Winter Seminar

RAMA-EGAT Risk Score for Predicting Coronary Artery Disease Evaluated by 64- Slice CT Angiography

Study of estimation of coronary artery calcium by multi-slice spiral CT scan in post myocardial infarction cases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Investigating the Frequency of Atherosclerosis Risk Factors in Patients Suffering from X Syndrome

Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score

Imaging-Guided Statin Allocation: Seeing Is Believing

Contemporary management of Dyslipidemia

Transcription:

Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring for Management of Asymptomatic Patients at Risk for Coronary Artery Disease? Who Cares About the Past? Blaha, M. Circ Cardiovasc Imaging. 2014;7:398-408 Why Is Subclinical Disease Superior to Risk Factor Assessment? Family Hx Age Diabetes Integration of Risk Factors including Unknown Factors, Multiple SNPs Obesity Hypertension Subclinical Disease Reflects the Dosage of Risk Factors over time LDL HDL CAC Tobacco Fitness Quantifying Subclinical Disease Reflects the High Risk Patient-the vulnerable plaque does not 9p21 Unknown Microbiome 1

What is the extent of atherosclerosis at the time of coronary events? Coronary Atherosclerosis is a Diffuse, Not a Focal Disease Roberts WC. Am J Cardiol 1988:62; 142-143 Coronaries in Angina Diffuse CAD in Pts Ieth AMI and CABG Roberts WC Circulation 1976: 54(3) 388. Roberts WC. Am J Cardiol 1988:62 (1); 144-147 Glagov S, NEJM 1987;316:1371-5 Glagov S, NEJM 1987;316:1371-5 2

Angiographically unrecognized left main coronary artery disease. Glagov S, NEJM 1987;316:1371-5 Topol E J, and Nissen S E Circulation. 1995;92:2333-2342 Prognostic Value of Presence and Extent of Non-obstructive and Obstructive CAD By CT Angiography Atherosclerosis: what is it and why does it occur? Michael J. Davies Circ Cardiovasc Imaging. 2014;7:282-291. Br Heart J 1993;69(Supplement):S 3-S 11 The Quantitative Nature of the Relationship of the Extent of Coronary Artery Atherosclerosis and Coronary Heart Disease Risk Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011 Degree of Atherosclerosis in Standard Score Units John Gofman. Cardiology Digest February 1969: p.28-38 Weber BJ. JAMA. 2012;308(24):2577-2583 3

The Concept of Duration of Risk Factor Exposure Conventional Approach-Ignores Duration of Risk Factor Exposure Past and Future One Time Measurement In Older Patients Blaha, M. Circ Cardiovasc Imaging. 2014;7:398-408 Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension Lancet 2010; 375: 938 48 Hypertrophy What about the Cumulative Dosage of High Blood Pressure, Hypercholesterolemia and other Risk Factors? 4

Hyperlipidemia in Early Adulthood Increases Long- Term Risk of Coronary Heart Disease Duration of LDL Lowering using Mendelian Randomization Circulation 2015, 114: 1-20 Effect of Long-Term Exposure to Lower LDL Beginning Early in Life on the Risk of CAD A Mendelian Randomization Analysis The emerging data suggest that CHD risk is likely best expressed as a function of cumulative exposure to all risk determinants over a lifetime Ference BA. J Am Coll Cardiol 2012;60:2631 9 Blaha, M. Circ Cardiovasc Imaging. 2014;7:398-408 Is There a Role for Coronary Artery Calcium Scoring for Management of Asymptomatic Patients at Risk for Coronary Artery Disease? Does the Extent of Atherosclerosis or the Rate of Atherosclerosis Predict Future Coronary Events? Percentile vs. Score? Percentile Score vs. Total CAC/Plaque Burden= Prognosis Blaha, M. Circ Cardiovasc Imaging. 2014;7:398-408 Detrano NEJM Volume 358:1336-1345 5

Why Do Coronary Events Occur Almost Exclusively After Extensive Atherosclerosis is Present? The Role of Rheology Rheology and Atherosclerosis The role of shear stress in the pathogenesis of atherosclerosis The role of shear stress in the pathogenesis of atherosclerosis Cunningham, C. Laboratory Investigation (2005) 85, 9 23 Cunningham, C. Laboratory Investigation (2005) 85, 9 23 6

Carotid Flow Effects of Disturbed Flow on Vascular Endothelium Annu. Rev. Biomed. Eng. 1999. 01:299 329 Physiol Rev 91: 327 387, 2011; A shear gradient dependent platelet aggregation mechanism drives thrombus formation Rheology and Thrombosis Nesbitt WS, NATURE MEDICINE VOLUME 2009;15 (6) : 665 A shear gradient dependent platelet aggregation mechanism drives thrombus formation Nesbitt WS, NATURE MEDICINE VOLUME 2009;15 (6) : 665 Nesbitt WS, NATURE MEDICINE VOLUME 2009;15 (6) : 665 7

Disturbed Blood Flow Acutely Induces Activation and Apoptosis of the Human Vascular Endothelium Thus, our findings raise the idea that disturbed blood flow induces EMPs which may further promote endothelial dysfunction at distal sites, resulting in a feed-forward vicious cycle of vascular injury. Jenkins NT, Hypertension. 2013;61:615-621 8

The Future of Coronary Imaging There is a lot more clinical information in CT and CTA Images Natural History of Atherosclerotic Plaque Natural History of the Post Rupture Lesions Fibrous tissue Calcium Old Young 9

Old How do we best quantify this atherosclerosis progression on a CT scan? Young Youngest Younger # of Lesions in Range Steady Athero Progression-55 yo >100 20-100 5-20 0-5 Range Individual Plaque Score <0 # of Lesions in Range Steady Athero Progression 70 yo >100 20-100 5-20 0-5 Range Individual Plaque Score <0 Steady Athero Progression 45 yo Life Long Exposure (Homozygous 9P21) # of Lesions in Range >100 20-100 5-20 0-5 Range Individual Plaque Score <0 10

# of Lesions in Range Arrested Progression due to Rx >100 20-100 5-20 0-5 <0 Individual Plaque Score AF 73 M CAC=274, from low score age 63 MS->DM2 x 10 yrs # of Lesions in Range Late Onset due to Weight Gain Metabolic Syndrome or Young Patient >100 20-100 5-20 0-5 <0 Individual Plaque Score Is There a Role for Coronary Artery Calcium Scoring for Management of Asymptomatic Patients at Risk for Coronary Artery Disease? Blaha, M. Circ Cardiovasc Imaging. 2014;7:398-408 11

Noninvasive Assessment of Gender Differences in Coronary Plaque Composition with Multidetector Computed Tomographic Angiography Noninvasive Assessment of Plaque Characteristics With CTA in Symptomatic Type 2 Diabetic Patients CAC=150 CAC=400 CAC=300 CAC=500 Am J Cardiol 2010;105:453 458 Diabetes Care 30:1113 1119, 2007 Natural Hx of Atherosclerosis Progression Natural Hx of Atherosclerosis Progression Cumulative Atherosclerosis Wt Gain MS RXRX DM2 Familial Dyslipidemia pre/post menopause Metabolic Syndrome-> DM2 Treated Atherosclerosis Slowed Progression Cumulative Atherosclerosis RX RX Untreated Dyslipidemia Treated Atherosclerosis Slowed Progression Aggressively Treated Arrested Progression Menopause 10 20 30 40 50 60 70 80 Age Aggressively Treated Arrested Progression 10 20 30 40 50 60 70 80 Age Atherosclerosis Progression Patterns CAC=150 CAC=300 Thank You 55 yo Female 55 yo Male CAC=400 CAC=500 60 yo non-diabetic with CAD 60 yo diabetic with CAD 12

Monitoring Atherosclerosis Progression 13